ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

QGEN Qiagen NV

41.65
0.57 (1.39%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,406,780
Bid Price
Ask Price
News -
Day High 41.68

Low
35.8135

52 Week Range

High
49.1739

Day Low 41.06
Share Name Share Symbol Market Stock Type
Qiagen NV QGEN NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
0.57 1.39% 41.65 18:56:36
Open Price Low Price High Price Close Price Previous Close
41.10 41.06 41.68 41.65 41.08
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
13,887 1,406,780 US$ 41.50 US$ 58,374,949 - 35.8135 - 49.1739
Last Trade Type Quantity Price Currency
18:00:00 122,232 US$ 41.65 USD

Qiagen NV Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
9.5B 228.20M - 1.97B 341.3M 1.50 27.85
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Qiagen NV News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No QGEN Message Board. Create One! See More Posts on QGEN Message Board See More Message Board Posts

Historical QGEN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week39.6441.9439.6441.101,059,4622.015.07%
1 Month43.1543.4239.0340.99903,991-1.50-3.48%
3 Months43.5445.3839.0342.861,011,769-1.89-4.34%
6 Months37.978447.292535.813542.931,189,4363.679.67%
1 Year45.555549.173935.813543.961,167,802-3.91-8.57%
3 Years53.204759.792235.813547.39941,668-11.55-21.72%
5 Years39.885560.823125.566344.621,165,9121.764.42%

Qiagen NV Description

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (45% of 2021 sales), followed by EMEA (36%) and Asia-Pacific (19%).

Your Recent History

Delayed Upgrade Clock